Allergic Rhinitis Market - Top Companies and Manufacturers

Companies Dominating the Allergic Rhinitis Landscape

The allergic rhinitis market is driven by a competitive landscape curated by the presence of well-established and emerging key players. The major participants in the market are diversifying their portfolios and focusing on innovating biological therapies for treating allergic rhinitis. In addition, the trend of treatments using advanced technologies and growing emphasis on personalized healthcare solutions is fueling the allergic rhinitis market expansion.

Here’s the list of some key players:

Bayer AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
GlaxoSmithKline plc
Sanofi
Glenmark Pharmaceuticals Limited
AstraZeneca
Merck & Co.,
Novartis AG
Meda Pharmaceuticals

Browse Key Market Insights with Data Illustration:

Allergic Rhinitis Market Size & Share, Growth Trends 2037

In the News

In November 2024, ARS Pharmaceuticals, Inc. announced a licensing agreement with ALK-Abelló A/S. In this agreement, ALK has gained the exclusive rights to commercialize neffy (epinephrine nasal spray), EURneffy in Europe as the first and only needle-free emergency treatment for Type I allergic reactions including anaphylaxis.
In March 2024, Entod Pharmaceuticals announced the launch of a state-of-the-art novel probiotic, Lactoshield RH. This treatment is effective for treating nasal allergies and managing other allergies rhinitis.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the allergic rhinitis market was estimated at over USD 15.4 billion.

The market size of the allergic rhinitis market is projected to cross USD 23.5 billion by the end of 2037 expanding at a CAGR of 3.6% during the forecast period i.e., between 2025-2037.

The major players in the market are Bayer AG, Sanofi, Merck & Co., Novartis AG, AstraZeneca, Johnson & Johnson Services, and others.

Based on the route of administration, the nasal & others segment is anticipated to garner the largest market share of 55.3% by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 45.5% by the end of 2037 and provide more business opportunities in the future.

Allergic Rhinitis Market - Top Companies and Manufacturers

Companies Dominating the Allergic Rhinitis Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the allergic rhinitis market?

What is the outlook for the allergic rhinitis market?

Who are the major players dominating the allergic rhinitis market?

Which segment will capture the significant market share for the allergic rhinitis market by 2037?

Which region will provide more business opportunities for the growth of the allergic rhinitis market in the future?